Australia B2B Canada Economy Europe India Investment Manufacturer Manufacturing Revenue United States
Synopsis Gland Pharma shares fell 3% after 1.22 crore shares changed hands in two block deals worth nearly Rs 5,818 crore. Reports suggested promoter Fosun Pharma Industrial was looking to sell a 5% stake in the company. Fosun held a 51.77% stake as of June 30, 2026, according to BSE data, making it the likely seller Shares of Gland Pharma declined 3% to the day’s low of Rs 2,827 on the BSE on Friday after 1.22 crore shares changed hands in two separate block deals worth Rs 2,941 crore and Rs 2,877 crore, respectively. According to various reports, Fosun Pharma…
News Timeline:
Track the development of this news story across the Internet.